B
WST icon

Bayban’s West Pharmaceutical WST Stock Holding History

Bayban’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.97K Hold
25
– – 0.01% 414
2026
Q1 		$6.27K Sell
25
-74
-75% -$18.4K 0.01% 451
2025
Q4 		$27.2K Buy
+99
New +$27.1K 0.02% 290

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bayban's WST Position: Q2 2026 in Review

Bayban held its West Pharmaceutical (WST) position steady in Q2 2026 at 25 shares worth $8.97K. The position accounts for 0.01% of the portfolio, ranked #414.

Bayban first reported a position in WST in Q4 2025 and has held it in 3 quarters since. The position peaked at $27.2K in Q4 2025. 785 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Bayban held 25 shares of West Pharmaceutical worth $8.97K as of Q2 2026.
  • Bayban left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up 0.01% of Bayban's portfolio in Q2 2026, its #414 holding.
  • Bayban first reported a position in West Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • Bayban's West Pharmaceutical position peaked at $27.2K in Q4 2025.
  • 785 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Bayban's 13F filing for Q2 2026, filed 30 Jul 2026.